Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inovio Pharmaceuticals Inc (NASDAQ:INO)

7.21
Delayed Data
As of 4:14pm ET
 -0.19 / -2.57%
Today’s Change
6.33
Today|||52-Week Range
13.04
-21.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues9.8M4.1M13.5M10.5M
 
 
 
 
 
Depreciation And Amortization2.0M2.0M2.1M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.0M26.8M32.9M48.4M
 
 
 
 
 
Research And Development20.0M18.0M21.4M34.1M
 
 
 
 
 
Total Operating Expenses32.0M28.8M35.0M50.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.2M-24.6M-21.5M-39.5M
 
 
 
 
 
Extraordinary Credit8.7M2.0M--3.0M
 
 
 
 
Extraordinary Charge0.000.00-46.7M--
 
 
Pre-Tax Equity Earnings-2.4M1.6M----
 
 
 
Other Expenses587.0K1.2M2.0M331.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.3M-19.7M-66.1M-36.1M
 
 
 
 
 
Minority Interest-51.2K-44.0K-55.1K-18.4K
 
 
 
 
 
Net Income-15.3M-19.7M-66.0M-36.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.6M34.1M46.1M59.1M
 
 
 
 
 
Shares To Calculate EPS Diluted31.6M34.1M46.1M59.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.56-$1.44-$0.64
 
 
 
 
 
EPS Diluted-$0.48-$0.56-$1.44-$0.64